|
| Press Releases |
|
 |
|
| Friday, August 25, 2023 |
|
|
China Everbright Limited Announces 2023 Interim Results, Realises Turnaround of Loss to Profit |
| On 25 August 2023, China Everbright Limited ("CEL" or the "Company", stock code: 165.HK) announced its interim results for the six months ended 30 June 2023 ("the reporting period"). more info >> |
|
| Friday, March 17, 2023 |
|
|
光大控股公布2022年全年业绩 |
| 中国光大控股有限公司(“光大控股”,股份代号:165.HK)公布截至2022年12月31日止12个月(“报告期”)之全年业绩。 more info >> |
|
|
光大控股公佈2022年全年業績 |
| 中國光大控股有限公司(「光大控股」,股份代號:165.HK)公佈截至2022年12月31日止12個月(「報告期」)之全年業績。 more info >> |
|
|
China Everbright Limited Announces 2022 Annual Results |
| China Everbright Limited ("CEL" or "the Group", stock code: 165.HK) today announced its annual results for the year ended 31 December 2022 ("the reporting period"). more info >> |
|
| Thursday, August 25, 2022 |
|
|
光大控股公布2022年中期业绩 |
2022年8月25日,中国光大控股有限公司(「光大控股」,股份代号:165.HK)公布截至2022年6月30日止之中期业绩。 more info >> |
|
|
光大控股公佈2022年中期業績 |
| 2022年8月25日,中國光大控股有限公司(「光大控股」,股份代號:165.HK)公佈截至2022年6月30日止之中期業績。 more info >> |
|
| Tuesday, July 5, 2022 |
|
|
光控海外基礎設施基金二期獲亞投行承諾出資1億美元 |
| 中國光大控股有限公司 (「光大控股」,股份代號:165.HK) 發起並管理的光控海外基礎設施基金二期(以下簡稱「二期基金」)募資取得重要進展。 more info >> |
|
|
AIIB Commits US$100 million in CEL Infrastructure Investment Fund II |
| CEL Infrastructure Investment Fund II ("Fund II"), a private equity fund sponsored and managed by China Everbright Limited ("CEL", stock code: 165.HK) has made significant progress in fundraising. more info >> |
|
| Wednesday, April 6, 2022 |
|
|
守望相助 愛心送暖 光大控股與中飛租賃向新界捐贈防疫物資 |
| 香港第五波疫情仍處攻堅關鍵期,4月4日,光大控股 (165.HK)和旗下中飛租賃(1848.HK)聯合向新界基層義工及兩家養老機構捐贈逾百箱防疫物資,全力支持基層一線義工和在院長者防疫抗疫。 more info >> |
|
| Thursday, March 17, 2022 |
|
|
穩健增長 逆勢上揚 光大控股公佈2021年全年業績 |
| 中國光大控股有限公司 (「光大控股」,股份代號:165.HK) 公佈截至2021年12月31日止之全年業績。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
テンストレント、完全オープンソーススタックを搭載した初のRISC-V AIワークステーション「TT-QuietBox(TM) 2」を発表。テラフロップス級推論を実現
Mar 12, 2026 01:00: JST
|
|
|
Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference
Mar 12, 2026 01:00: JST
|
|
|
Tenstorrent Unveils TT-QuietBox(TM) 2, the First RISC-V AI Workstation With a Fully Open-Source Stack to Deliver Teraflop-Class Inference
Mar 12, 2026 00:00 HKT/SGT
|
|
|
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis
Mar 11, 2026 20:15: JST
|
|
|
Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025
Mar 11, 2026 19:16 HKT/SGT
|
|
|
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis
Mar 11, 2026 20:15 JST
|
|
|
云顶新耀维适平(R)中国大陆首张处方落地 填补中重度溃疡性结肠炎治疗空白
Mar 11, 2026 19:15 HKT/SGT
|
|
|
雲頂新耀維適平(R)中國大陸首張處方落地 填補中重度潰瘍性結腸炎治療空白
Mar 11, 2026 19:15 HKT/SGT
|
|
|
越秀房產基金經營保持韌性 2025年收入逾人民幣18億元
Mar 11, 2026 19:00 HKT/SGT
|
|
|
越秀房产基金经营保持韧性 2025年收入逾人民币18亿元
Mar 11, 2026 18:38 HKT/SGT
|
|
|
MarketingPulse and eTailingPulse open next Thursday
Mar 11, 2026 16:54 HKT/SGT
|
|
|
エーザイ、アルツハイマー・パーキンソン病学会(AD/PD 2026)において、レカネマブの長期実臨床治療をはじめとするアルツハイマー病の最新知見を発表
Mar 11, 2026 11:30: JST
|
|
|
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting
Mar 11, 2026 12:07 JST
|
|
|
JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY
Mar 11, 2026 09:40 HKT/SGT
|
|
|
歡聚集團發布2025年Q4財報及全年財報:BIGO Ads加速增長 股東回報強勁
Mar 11, 2026 09:40 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|